Name: CJC-1295 (NO DAC) 5MG
Brand: PrymaLab
SKU: PL-CJC1295-5MG-VIAL
Price: 24.99 USD
Availability: InStock

Description

CJC-1295 without DAC is GHRH(1-29) amide with four residues replaced and no albumin-binding group. This vial holds 10 mg of it as freeze-dried powder, twice the 5 mg main fill, and it is made and tested as a separate lot. Much of the research filed under the CJC-1295 name concerns the DAC version, and the main fill page sorts out which findings apply to this peptide.

Specifications

CJC-1295 (NO DAC) 10MG at a glance
Property	Value
Compound	CJC-1295 (no DAC) Modified GRF (1-29); tetrasubstituted GHRH(1–29) analogue (D-Ala2, Gln8, Ala15, Leu27)
CAS number	863288-34-0
Molecular formula	C₁₅₂H₂₅₂N₄₄O₄₂
Theoretical mass	3367.9 Da
Sequence / structure	`H-Y-[D-Ala]-DAIFTQSYRKVLAQLSARKLLQDILSR-NH₂ (29 residues; C-terminal amide)`
Label claim	10 mg/vial
Form	Lyophilized (freeze-dried) powder or cake in a sealed glass vial with a rubber stopper and aluminium crimp cap
Storage, sealed	−20 °C, desiccated, dark
Purity specification	99.0% or higher by RP-HPLC
Lot certificate	Results for the lot now shipping are in the certificate panel on this page
Safety data sheet	PL-SDS-039

Other fills

This is the 10 mg fill. The CJC-1295 (NO DAC) 5MG page is the main listing for this compound, with the full research summary and every fill side by side. Other fills: 5 mg.

What the research covers

The original CJC-1295 paired a substituted GRF(1-29) chain with an added maleimide-carrying lysine that attaches to albumin, and the long persistence in rat plasma was measured for that conjugating version¹. This vial contains the substituted 29-residue chain alone, which has no group able to attach to albumin and has not been studied on its own in the papers cited here. The CJC-1295 (no DAC) 5 mg page has the full research summary and the comparison with the DAC form.

The CJC-1295 + Ipamorelin Blend guide covers the literature in more depth.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. The results for the lot now shipping are in the certificate panel on this page, and the certificate number, key and QR code can be checked on the verify page. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

Is the 10 mg vial the same peptide as the 5 mg vial?

Yes: the same 29-residue modified GRF(1-29) with a theoretical mass of 3367.9 Da. In molar terms 10 mg is about 3.0 µmol, a little less after the certificate's water content. The 10 mg fill has its own lot number and certificate.

Is a larger fill harder to store?

Sealed, it is kept like the smaller vial: −20 °C, dry and dark. After reconstitution a bigger fill usually means solution held longer at 2 to 8 °C, so size the volume to how quickly the work will use it.

Is this vial for human use?

No. It is sold only for laboratory research, is not approved by the FDA or any other authority for human or veterinary use, and must not be given to people or animals.

References

Jetté L, Léger R, Thibaudeau K, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146(7):3052-8. DOI · PubMed

Research use only

For laboratory research use only. CJC-1295 (NO DAC) 10MG is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Other formats of CJC-1295

CJC-1295 is also stocked as CJC-1295 (no DAC), Ipamorelin 10mg (Blend), Ipamorelin 10mg Nasal Spray, CJC-1295 (No DAC) + Ipamorelin 15mg preloaded 3ml pen, Ipamorelin 5mg and Ipamorelin 10mg. Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats.

Additional information

Weight	N/A
Dimensions	N/A

Lot PL-2609-023 · Certificate of Analysis PL-26-00023

Every lot is tested in our own laboratory before it ships. These are the reference facts for this compound and the results for the lot currently shipping. Open the certificate page to verify it by QR code or number.

Compound	CJC-1295 (no DAC) Modified GRF (1-29); tetrasubstituted GHRH(1–29) analogue (D-Ala2, Gln8, Ala15, Leu27)
CAS number	863288-34-0
Molecular formula	C₁₅₂H₂₅₂N₄₄O₄₂
Theoretical mass	3367.9 Da
Sequence / structure	`H-Y-[D-Ala]-DAIFTQSYRKVLAQLSARKLLQDILSR-NH₂ (29 residues; C-terminal amide)`
Appearance	White lyophilized powder
Storage	−20 °C, desiccated, dark
Label claim	10 mg/vial
Lot number	`PL-2609-023`
Certificate number	`PL-26-00023`
Date of analysis	2026-09-18 (retest 2028-09-17)
Purity (RP-HPLC)	99.77%
Identity (LC-MS)	3368.1 Da
Water content (KF)	1.7%
Endotoxin (LAL)	0.05 EU/mg
Sterility	No growth; conforms
Conclusion	PASS
Tested by	PrymaLab Analytical (PrymaLab's own laboratory, Ashland, KY). In-house result, not an independent third-party test.

Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.

Certificate of analysis for lot PL-2609-023, page 1 — Certificate page 1: results

Certificate of analysis for lot PL-2609-023, page 2 — Certificate page 2: method and approval

Download the COA (PDF) Verify certificate PL-26-00023 All published results

Safety data sheet PL-SDS-039 · CJC-1295 (no DAC)

GHS safety data sheet for this product (lyophilized powder, vial), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Not classified as hazardous Not classified under OSHA HCS 2012 / GHS. No pictogram, signal word or hazard statement is required; handle as a pharmacologically active laboratory chemical.

Composition	CJC-1295 (no DAC) (CAS 863288-34-0) · ≥ 95% (dry basis, as supplied), 5 mg, 10 mg per vial
Classification	Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Physical state	Solid. White to off-white lyophilized powder.
Storage	−20 °C (sealed vial), desiccated and protected from light; 2–8 °C acceptable for short periods
Handling	Open vials only in a clean area. Avoid generating or inhaling dust; weigh or reconstitute inside a ventilated enclosure when the full contents are handled as a dry powder. Reconstitute by adding diluent slowly to the vial wall; do not shake. Wash hands after handling.
First aid	Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Disposal	Chemical waste through a licensed contractor; do not pour down the drain.
Transport	Not regulated as a dangerous good (DOT / IATA / IMDG).

Download the SDS (PDF) Read the full safety data sheet All safety data sheets

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

CJC-1295 (NO DAC) 10MG

Description